<- Go Home
Neuland Laboratories Limited
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Market Cap
INR 147.6B
Volume
3.8K
Cash and Equivalents
INR 2.6B
EBITDA
INR 3.2B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
INR 7.3B
Profit Margin
49.18%
52 Week High
INR 18.1K
52 Week Low
INR 5.6K
Dividend
0.10%
Price / Book Value
9.68
Price / Earnings
56.73
Price / Tangible Book Value
11.90
Enterprise Value
INR 145.5B
Enterprise Value / EBITDA
45.00
Operating Income
INR 2.6B
Return on Equity
18.53%
Return on Assets
8.03
Cash and Short Term Investments
INR 3.7B
Debt
INR 1.6B
Equity
INR 15.2B
Revenue
INR 14.8B
Unlevered FCF
INR 1.1B
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium